5497 |
Mitraclip À» À§ÇÑ ½Ã¼ú½Ç Áغñ, Puncture to Close |
Do-Yoon Kang |
Aug. 01. 22 |
5496 |
´ë»ó ȯÀÚ Ã£±â: ½ÉÃÊÀ½ÆÄ ½ºÅ©¸®´×ÀÇ ¸ðµç °Í |
Seung-Ah Lee |
Aug. 01. 22 |
5495 |
Long-Term Valve Durability Issues and Optimal Decision-Making: TAVR or SAVR, Mechanical or Bioprosthetic? |
Duk-Woo Park |
Aug. 01. 22 |
5494 |
Next Target for Valve Pharmacology: Mechanical Valve Revisited with NOAC - RENOVATE Trial |
Joon Bum Kim |
Aug. 01. 22 |
5493 |
Key Message from the ADAPT-TAVR Trial: What We Learned? |
Duk-Woo Park |
Aug. 01. 22 |
5492 |
Optimal Indication for Cerebral Embolic Protection for TAVR: Insights from the TVT Registry |
David Joel Cohen |
Aug. 01. 22 |
5491 |
Balloon-expandable vs. Self-expandable TAVR for Bicuspid Valve: When or How? |
James Flaherty |
Aug. 01. 22 |
5490 |
TAVR for Bicuspid Valve: Practical Tips and Tricks for Optimal Sizing and Positioning |
Jung-Min Ahn |
Aug. 01. 22 |
5489 |
The Last 10 Year TAVR Path and Achievement of ASAN MEDICAL CENTER |
Seung-Jung Park |
Aug. 01. 22 |
5488 |
Next Innovation in Transcatheter Valve Intervention: New Techniques and New Valves |
Eberhard Grube |
Aug. 01. 22 |